CKPT Checkpoint Therapeutics, Inc Yalpi marja

Checkpoint Therapeutics, Inc (CKPT) kompaniyasining rasmiy ramzlari

Checkpoint Therapeutics teri saratoni bilan kurashish uchun hamyonbop immunoterapiyani ishlab chiqadi. Val gross profit margin joriy foyda dinamikasini aks ettiradi va uning qiymati 0.00 darajasida barqarorlashgan. Kelgusidagi daromadlar tartibga soluvchi organlar tomonidan tasdiqlangandan so'ng cosibelimab antitelosining tijoratlashtirilishiga bog'liq. Kompaniyaning patent portfeli va klinikalarga bo'lgan sherikliklari sotuvlar bo'yicha uzoq muddatli monopoliyani kafolatlaydi.

Checkpoint Therapeutics, Inc - CKPT Yalpi rentabellik (davr: 04.07.2022 - 07.06.2025)

Checkpoint Therapeutics, Inc. (CKPT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning jamlanma tahlili:Checkpoint Therapeutics, Inc - CKPT
checkpointtx.com seriyali mahsuloti

Checkpoint Therapeutics (CKPT) uchun immunoterapiyani ishlab chiqish samaradorligi bevosita ishlab chiqarish xarajatlarini minimallashtirish qobiliyatida aks etadi. Valo martja daromadliligini tahlil qilish orqali investor sotilgan tovarlar tannarxini qoplagandan keyin qolgan tushum qismini ko'rishi mumkin, bu esa haqiqiy ishlab chiqarish samaradorligini tasdiqlaydi. Kelajakda cosibelimab ning tijoratga chiqarilishi va uning raqobatchilarga nisbatan narx belgilash imkoniyati ushbu ko'rsatkichni tijorat muvaffaqiyatining asosiy indikatoriga aylantirishi kerak.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik